The ongoing legal battles between health insurers and the Centers for Medicare and Medicaid Services (CMS) over Medicare Advantage star ratings have once again led to a recalculation of these ratings for 2026. This is a significant development that has implications for both the healthcare industry and taxpayers. Personally, I think this situation highlights the complex and often contentious relationship between private insurers and the government in the Medicare Advantage program. What makes this particularly fascinating is the sheer scale of the bonuses at stake, which have grown to $16 billion this year, a figure that has doubled since 2020. (Read more…)
Lesen Sie den vollständigen Artikel auf Papierkugel - All About Everything.